Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker MRNA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 39,145 | $8.6M | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 1 day later · 78,369 shares | Form 144 ↗ |
| Oct 14, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 39,224 | $8.4M | 10b5-1 | Oct 14, 2026 | Form 4 ↗ 2 days later · 78,369 shares | Form 144 ↗ |
| Sep 15, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 40,281 | $5.9M | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 1 day later · 80,575 shares | Form 144 ↗ |
| Sep 14, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 40,294 | $5.8M | 10b5-1 | Sep 14, 2026 | Form 4 ↗ 2 days later · 80,575 shares | Form 144 ↗ |
| Sep 10, 2026 | James M. Mock Officer | MRNA Moderna, Inc. | 34,836 | $4.7M | 10b5-1 | Sep 10, 2026 | Form 4 ↗ 4 days later · 34,836 shares | Form 144 ↗ |
| Sep 1, 2026 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 3,471 | $485.8K | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 2 days later · 3,471 shares | Form 144 ↗ |
| Aug 5, 2026 | Bancel Stephane Officer, Director | MRNA Moderna, Inc. | 499,246 | $29.0M | 10b5-1 | Aug 5, 2026 | Form 4 ↗ 2 days later · 499,246 shares | Form 144 ↗ |
| Jul 15, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 53,336 | $3.6M | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 1 day later · 53,336 shares | Form 144 ↗ |
| Jun 18, 2026 | Paul Sagan Former Director | MRNA Moderna, Inc. | 25,770 | $1.7M | — | Jun 18, 2026 | — | Form 144 ↗ |
| Jun 15, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 53,336 | $2.7M | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 53,336 shares | Form 144 ↗ |
| Jun 4, 2026 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 3,471 | $173.6K | 10b5-1 | Jun 4, 2026 | Form 4 ↗ 4 days later · 3,471 shares | Form 144 ↗ |
| May 21, 2026 | Flagship Pioneering, LLC Affiliate | MRNA Moderna, Inc. | 9,263 | $433.9K | — | May 21, 2026 | — | Form 144 ↗ |
| May 15, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 53,336 | $2.6M | 10b5-1 | May 15, 2026 | Form 4 ↗ 3 days later · 53,336 shares | Form 144 ↗ |
| May 8, 2026 | Paul Sagan Former Director | MRNA Moderna, Inc. | 36,759 | $2.0M | — | May 8, 2026 | — | Form 144 ↗ |
| May 1, 2026 | Hussain Abbas Director | MRNA Moderna, Inc. | 5,682 | $265.0K | 10b5-1 | May 1, 2026 | Form 4 ↗ 3 days later · 5,682 shares | Form 144 ↗ |
| Mar 2, 2026 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 13,885 | $726.0K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 1 day later · 13,885 shares | Form 144 ↗ |
| Feb 23, 2026 | Stephen Hoge Officer | MRNA Moderna, Inc. | 160,009 | $7.8M | 10b5-1 | Feb 23, 2026 | Form 4 ↗ 2 days later · 160,009 shares | Form 144 ↗ |
| Dec 11, 2025 | Flagship Pioneering Inc. Affiliate | MRNA Moderna, Inc. | 23,853 | $703.3K | — | Dec 11, 2025 | — | Form 144 ↗ |
| Dec 9, 2025 | Hussain Abbas Director | MRNA Moderna, Inc. | 504 | $13.9K | 10b5-1 | Dec 9, 2025 | Form 4 ↗ 2 days later · 504 shares | Form 144 ↗ |
| Jun 11, 2025 | Hussain Abbas Director | MRNA Moderna, Inc. | 312 | $8,736 | 10b5-1 | Jun 11, 2025 | Form 4 ↗ 1 day later · 312 shares | Form 144 ↗ |
| Dec 9, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 529 | $23.6K | — | Dec 9, 2024 | Form 4 ↗ 1 day later · 529 shares | Form 144 ↗ |
| Dec 3, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 112 | $4,849 | — | Dec 3, 2024 | Form 4 ↗ 1 day later · 112 shares | Form 144 ↗ |
| Dec 3, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 314 | $13.6K | — | Dec 3, 2024 | Form 4 ↗ 1 day later · 314 shares | Form 144 ↗ |
| Nov 29, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 291 | $12.5K | — | Nov 29, 2024 | Form 4 ↗ 3 days later · 291 shares | Form 144 ↗ |
| Nov 29, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 1,418 | $60.7K | — | Nov 29, 2024 | Form 4 ↗ 3 days later · 1,418 shares | Form 144 ↗ |
| Nov 29, 2024 | James M. Mock Officer | MRNA Moderna, Inc. | 1,420 | $60.8K | — | Nov 29, 2024 | Form 4 ↗ 3 days later · 1,420 shares | Form 144 ↗ |
| Nov 12, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 277 | $12.8K | — | Nov 11, 2024 | Form 4 ↗ 20 days later · 291 shares | Form 144 ↗ |
| Oct 7, 2024 | James M. Mock Officer | MRNA Moderna, Inc. | 715 | $43.0K | — | Oct 7, 2024 | Form 4 ↗ 1 day later · 715 shares | Form 144 ↗ |
| Sep 9, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 551 | $40.5K | — | Sep 9, 2024 | Form 4 ↗ 84 days later · 1,418 shares | Form 144 ↗ |
| Sep 3, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 114 | $8,777 | — | Sep 3, 2024 | Form 4 ↗ 90 days later · 1,418 shares | Form 144 ↗ |
| Sep 3, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 318 | $24.5K | — | Sep 3, 2024 | Form 4 ↗ 70 days later · 277 shares | Form 144 ↗ |
| Aug 29, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 162 | $12.6K | — | Aug 29, 2024 | — | Form 144 ↗ |
| Aug 29, 2024 | James M. Mock Officer | MRNA Moderna, Inc. | 162 | $12.6K | — | Aug 29, 2024 | Form 4 ↗ 40 days later · 715 shares | Form 144 ↗ |
| Aug 29, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 300 | $23.4K | — | Aug 29, 2024 | Form 4 ↗ 75 days later · 277 shares | Form 144 ↗ |
| Aug 28, 2024 | James M. Mock Officer | MRNA Moderna, Inc. | 1,321 | $104.9K | — | Aug 28, 2024 | Form 4 ↗ 41 days later · 715 shares | Form 144 ↗ |
| Aug 28, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 1,319 | $104.7K | — | Aug 28, 2024 | — | Form 144 ↗ |
| Aug 12, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 254 | $21.4K | — | Aug 12, 2024 | — | Form 144 ↗ |
| Jul 31, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $1.8M | 10b5-1 | Jul 31, 2024 | — | Form 144 ↗ |
| Jul 24, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $1.8M | 10b5-1 | Jul 24, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $1.9M | 10b5-1 | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 15, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 15,000 | $1.8M | 10b5-1 | Jul 15, 2024 | — | Form 144 ↗ |
| Jul 10, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $1.7M | 10b5-1 | Jul 10, 2024 | — | Form 144 ↗ |
| Jul 8, 2024 | James M. Mock Officer | MRNA Moderna, Inc. | 689 | $81.5K | — | Jul 8, 2024 | — | Form 144 ↗ |
| Jun 26, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $2.1M | 10b5-1 | Jun 26, 2024 | — | Form 144 ↗ |
| Jun 18, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $2.1M | 10b5-1 | Jun 18, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Stephen Hoge Officer | MRNA Moderna, Inc. | 15,000 | $2.1M | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 12, 2024 | Noubar B Afeyan Director | MRNA Moderna, Inc. | 15,000 | $2.2M | 10b5-1 | Jun 12, 2024 | — | Form 144 ↗ |
| Jun 11, 2024 | Flagship Ventures Fund IV-Rx, L.P. Affilate | MRNA Moderna, Inc. | 32,763 | $4.9M | — | Jun 11, 2024 | — | Form 144 ↗ |
| Jun 11, 2024 | Flagship Ventures Fund IV LP Affilate | MRNA Moderna, Inc. | 170,069 | $25.2M | — | Jun 11, 2024 | — | Form 144 ↗ |
| Jun 10, 2024 | Klinger Shannon Thyme Officer | MRNA Moderna, Inc. | 5,178 | $766.8K | — | Jun 10, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 11:05 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances